Grail (GRAL) Income from Continuing Operations (2023 - 2026)
Grail's (GRAL) quarterly Income from Continuing Operations came in at 93187000.0 in Q1 2026, up 12.26% YoY from 83006992.94 in Q1 2025, and up 6.04% on a QoQ basis from 99176000.0 in Q4 2025.
Grail (GRAL) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Grail (GRAL) has 4 years of Income from Continuing Operations data on file, last reported at 93187000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 12.26% year-over-year to 93187000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 395325000.0 (up 79.35% YoY) and the FY2025 annual result came in at 408351000.0, up 79.85% from the prior year.
- Income from Continuing Operations climbed to 93187000.0 in Q1 2026, from 99176000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 88977000.0 in Q3 2025 to a low of 1585337000.0 in Q2 2024.
- A 4-year average of 316713500.0 and a median of 119836500.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations tumbled 721.23% — and 2025, when it jumped 92.81%.
- Tracing GRAL's Income from Continuing Operations over 4 years: stood at 187527000.0 in 2023, then soared by 48.24% to 97066000.0 in 2024, then declined by 2.17% to 99176000.0 in 2025, then advanced by 6.04% to 93187000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 93187000.0 (Q1 2026), 99176000.0 (Q4 2025), and 88977000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Grail | 3.56 Bn | 2.70 Bn | 21.34 Mn | -110.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -110.25 Mn |
| Mar 31, 2026 | -93.19 Mn |
| Dec 31, 2025 | -99.18 Mn |
| Sep 30, 2025 | -88.98 Mn |
| Jun 30, 2025 | -113.99 Mn |
| Mar 31, 2025 | -106.21 Mn |
| Dec 31, 2024 | -97.07 Mn |
| Sep 30, 2024 | -125.69 Mn |
| Jun 30, 2024 | -1.59 Bn |
| Mar 31, 2024 | -218.91 Mn |
| Dec 31, 2023 | -187.53 Mn |
| Oct 1, 2023 | -891.45 Mn |
| Jun 30, 2023 | -193.04 Mn |